298
KNDP 당뇨병 임상 진료지침 Clinical Practice Guidelines

ations in the management of diabetic retinopathy. Am J Ophthalmol 2001;132:760-76.
55. lone acetonide vitreous inserts for diabetic macular edema. Ophthalmology 2011;118:626-35.
47. Early Treatment Diabetic Retinopathy Study Research Group. Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Ophthalmology 1991;98(5 Suppl):757-65.
56. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. Arch Ophthalmol 1990;108:958-64.
48. Chew EY, Ferris 3rd FL, Csaky KG, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic follow-up study. Ophthalmology 2003;110:1683-9.
57. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial-Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group. Ophthalmology 1988;95:1307-20.
49. Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema: results from 2 phase iii randomized trials: RISE and RIDE. Ophthalmology 2012;119:789-801.
58. Smiddy WE, Flynn Jr HW. Vitrectomy in the management of diabetic retinopathy. Surv Ophthalmol 1999;43:491-507.
50. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-25.
59. El-Asrar AM, Al-Mezaine HS, Ola MS. Changing paradigms in the treatment of diabetic retinopathy. Curr Opin Ophthalmol 2009;20:532-8.
51. Elman MJ, Bressler NM, Qin H, et al. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011;118:609-14.
60. Chew EY, Klein ML, Murphy RP, et al. Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. Arch Ophthalmol 1995;113:52-5.
52. Rajendram R, Fraser-Bell S, Kaines A, et al. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema. Arch Ophthalmol 2012;130:972-9.
61. Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 1999;117:1600-6.
53. Pearson PA, Comstock TL, Ip M, et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology 2011;118:1580-7.
62. Brown JS, Mahmoud TH. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina 2011; 31:1983-7.
54. Campochiaro PA, Brown DM, Pearson A, et al. Long-term benefit of sustained-delivery fluocino-
63. Fonda GE. Optical treatment of residual vision in diabetic retinopathy. Ophthalmology 1994;101:84-8.
Bernbaum M, Albert SG. Referring patients with diabetes and vision loss for rehabilitation: who is responsible? Diabetes Care 1996;19:175-7.